Schütz-Fuhrmann, IngridIngridSchütz-FuhrmannRami-Merhar, BirgitBirgitRami-MerharFröhlich-Reiterer, ElkeElkeFröhlich-ReitererHofer, Sabine ESabine EHoferTauschmann, MartinMartinTauschmannMader, Julia KJulia KMaderResl, MichaelMichaelReslKautzky-Willer, AlexandraAlexandraKautzky-WillerWinhofer-Stöckl, YvonneYvonneWinhofer-StöcklLaimer, MarkusMarkusLaimer0000-0002-7622-0822Zlamal-Fortunat, SandraSandraZlamal-FortunatWeitgasser, RaimundRaimundWeitgasser2024-10-252024-10-252023-01https://boris-portal.unibe.ch/handle/20.500.12422/166702This Guideline represents the recommendations of the Austrian Diabetes Association (ÖDG) on the use of diabetes technology (insulin pump therapy; continuous glucose monitoring, CGM; hybrid closed-loop systems, HCL; diabetes apps) and access to these technological innovations for people with diabetes mellitus based on current scientific evidence.deAID Artificial pancreas CGM Closed-loop Diabetes technology Insulin pump therapy Mobile apps Telemedicine Threshold-suspension600 - Technology::610 - Medicine & healtharticle10.48350/1820123710102510.1007/s00508-023-02165-9